Squarepoint Ops LLC Infla Rx N.V. Transaction History
Squarepoint Ops LLC
- $96.1 Billion
- Q3 2025
A detailed history of Squarepoint Ops LLC transactions in Infla Rx N.V. stock. As of the latest transaction made, Squarepoint Ops LLC holds 188,523 shares of IFRX stock, worth $250,735. This represents 0.0% of its overall portfolio holdings.
Number of Shares
188,523
Previous 146,034
29.1%
Holding current value
$250,735
Previous $115,000
113.91%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding IFRX
# of Institutions
31Shares Held
19.2MCall Options Held
52KPut Options Held
0-
Suvretta Capital Management, LLC New York, NY6.48MShares$8.62 Million0.25% of portfolio
-
Bank Of America Corp Charlotte, NC2.48MShares$3.29 Million0.0% of portfolio
-
683 Capital Management, LLC New York, NY2.25MShares$2.99 Million0.17% of portfolio
-
Ra Capital Management, L.P. Boston, MA1.97MShares$2.62 Million0.04% of portfolio
-
Eversept Partners, LP New York, NY1.73MShares$2.3 Million0.18% of portfolio
About InflaRx N.V.
- Ticker IFRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,203,800
- Market Cap $58.8M
- Description
- InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...